Resumen: Background. To compare the efficacy and safety of a new ocular insert versus conventional mydriasis in cataract surgery. Methods. We selected 70 patients undergoing cataract surgery. Thirty five patients (Group 1) received instillation of mydriatic drops (tropicamide 1%, phenylephrine 10%, and cyclopentolate 1%) prior to surgery, and 35 patients (Group 2) had a Mydriasert insert (Théa Pharma) (0.28¿mg of tropicamide and 5.4¿mg of phenylephrine hydrochloride) placed in the inferior fornix. Pupil size before and after surgery, blood pressure, and heart rate were measured. Results. Before surgery, pupil diameter was ¿mm in Group 1 and in Group 2 ( ). Twenty four hours after surgery, pupil diameter was ¿mm in Group 1 and in Group 2 ( ). There were no statistically significant differences in blood pressure or heart rate between groups. Conclusions. The effect of the Mydriasert insert was similar to conventional mydriatic agents. Pupil size was restored to normal faster when using the Mydriasert insert compared with conventional mydriatic agents for pupil dilation.
Idioma: Inglés
DOI: 10.1155/2013/849349
Año: 2013
Publicado en: BioMed Research International 2013 (2013), 849349 [4 pp]
ISSN: 2314-6133

Factor impacto JCR: 0.0 (2013)
Categ. JCR: MEDICINE, RESEARCH & EXPERIMENTAL
Categ. JCR: BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Tipo y forma: Article (Published version)
Área (Departamento): Oftalmología (Departamento de Cirugía, Ginecología y Obstetricia)
0
Exportado de SIDERAL (2016-12-16-14:54:35)

Este artículo se encuentra en las siguientes colecciones:
articulos > articulos-por-area > oftalmologia

Visitas


 Notice créée le 2016-12-16, modifiée le 2016-12-17


Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)